{"created":"2023-12-27T08:58:10.933118+00:00","id":2000056,"links":{},"metadata":{"_buckets":{"deposit":"608cfac6-3459-4e8f-8acf-3bac3eae9ecf"},"_deposit":{"created_by":15,"id":"2000056","owner":"15","owners":[15],"pid":{"revision_id":0,"type":"depid","value":"2000056"},"status":"published"},"_oai":{"id":"oai:air.repo.nii.ac.jp:02000056","sets":["611:968:969:1703583292145"]},"author_link":[],"control_number":"2000056","item_10006_alternative_title_32":{"attribute_name":"別タイトル","attribute_value_mlt":[{"subitem_alternative_title":"シタグリプチン、ミグリトールもしくはその併用療法を受けた 2 型糖尿病患者における食事負荷後の活性型GLP1・活性型GIP、骨格筋量及び体脂肪量の関係：MASTER 試験の二次解析","subitem_alternative_title_language":"ja"}]},"item_10006_date_granted_41":{"attribute_name":"学位授与年月日","attribute_value_mlt":[{"subitem_dategranted":"2023-09-29"}]},"item_10006_degree_grantor_40":{"attribute_name":"学位授与機関","attribute_value_mlt":[{"subitem_degreegrantor":[{"subitem_degreegrantor_language":"ja","subitem_degreegrantor_name":"秋田大学"}],"subitem_degreegrantor_identifier":[{"subitem_degreegrantor_identifier_name":"11401","subitem_degreegrantor_identifier_scheme":"kakenhi"}]}]},"item_10006_degree_name_39":{"attribute_name":"学位名","attribute_value_mlt":[{"subitem_degreename":"博士（医学）","subitem_degreename_language":"ja"}]},"item_10006_dissertation_number_42":{"attribute_name":"学位授与番号","attribute_value_mlt":[{"subitem_dissertationnumber":"甲第1479号"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"佐藤, 優洋","creatorNameLang":"ja"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2023-12-27"}],"filename":"ihakuyoushiokou1479.pdf","filesize":[{"value":"351 KB"}],"format":"application/pdf","mimetype":"application/pdf","url":{"label":"内容要旨及び審査結果要旨","objectType":"abstract","url":"https://air.repo.nii.ac.jp/record/2000056/files/ihakuyoushiokou1479.pdf"},"version_id":"dbadb9ad-7d2f-452f-9a8e-e31a48537242"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"doctoral thesis","resourceuri":"http://purl.org/coar/resource_type/c_db06"}]},"item_title":"Relationships among Postprandial Plasma Active GLP 1 and GIP Excursions, Skeletal Muscle Mass, and Body Fat Mass in Patients with Type 2 Diabetes Treated with Either Miglitol, Sitagliptin, or Their Combination: A Secondary Analysis of the MASTER Study","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Relationships among Postprandial Plasma Active GLP 1 and GIP Excursions, Skeletal Muscle Mass, and Body Fat Mass in Patients with Type 2 Diabetes Treated with Either Miglitol, Sitagliptin, or Their Combination: A Secondary Analysis of the MASTER Study","subitem_title_language":"en"}]},"item_type_id":"10006","owner":"15","path":["1703583292145"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2023-12-27"},"publish_date":"2023-12-27","publish_status":"0","recid":"2000056","relation_version_is_last":true,"title":["Relationships among Postprandial Plasma Active GLP 1 and GIP Excursions, Skeletal Muscle Mass, and Body Fat Mass in Patients with Type 2 Diabetes Treated with Either Miglitol, Sitagliptin, or Their Combination: A Secondary Analysis of the MASTER Study"],"weko_creator_id":"15","weko_shared_id":-1},"updated":"2024-01-11T09:24:52.311890+00:00"}